We present the post hoc analyses of a clinical trial and showed that both pre‐CRP and post‐CRPmax were closely associated with the recurrence for GC after R0 resection, and the predictive value of pre‐CRP was significantly greater than post‐CRPs. This evidence concerns the gene CRP and gastric cancer.